首页 | 本学科首页   官方微博 | 高级检索  
     


Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Authors:Minoko Takanashi  Eileen Selogie  Jo‐Anna Reems  David Stroncek  Magali J. Fontaine  John Girdlestone  Henk S. P. Garritsen  Pampee Young  David H. McKenna  Zbigniew M. Szczepiorkowski  for the Biomedical Excellence for Safer Transfusion Collaborative
Affiliation:1. Japanese Red Cross Society Blood Service Headquarters, Tokyo, Japan;2. Biomedical Excellence for Safer Transfusion (BEST) Collaborative, Dartmouth‐Hitchcock Medical Center, Lebanon, New Hampshire;3. University of Utah, Salt Lake City, Utah;4. Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland;5. Transfusion Services, Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland;6. Stem Cells and Immunotherapies, NHS Blood and Transplant, The John Radcliffe Hospital, Oxford, UK;7. Institute for Clinical Transfusion MedicineMunicipal Hospital Braunschweig gGmbH;8. Fraunhofer Institute for Surface Engineering and Thin Film IST, Braunschweig, Germany;9. Vanderbilt University, Nashville, Tennessee;10. Molecular & Cellular Therapeutics, University of Minnesota, Saint Paul, Minnesota;11. Dartmouth‐Hitchcock Medical Center, Lebanon, New Hampshire;12. Institute of Hematology and Transfusion Medicine, Warsaw, Poland
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号